menu
    • menu

    Company profile for ClearPoint Neuro

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. Additionally, ClearPoint is currently used in clinical trials for delivery of biologics, gene, and stem cell therapies to the brain. Our platform has FDA clearance, is CE-marked, an...
    ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. Additionally, ClearPoint is currently used in clinical trials for delivery of biologics, gene, and stem cell therapies to the brain. Our platform has FDA clearance, is CE-marked, and is installed in over 60 active clinical sites in the United States, Canada, and Europe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ClearPoint NeuroUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    120 S. Sierra Ave., Suite 100 Solana Beach, CA 92075
    Telephone
    Telephone
    888-287-9109
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.clearpointneuro.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clearpointneuro/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/intent/follow?source=followbutton&variant=1.0&screen_name=ClearPointNeuro

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clearpoint Neuro Unveils FDA-Cleared Velocity Alpha(R) MR Drill
    Clearpoint Neuro Unveils FDA-Cleared Velocity Alpha(R) MR Drill

    22 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-22/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alpha-r-mr-high-speed-surgical-drill-syste

    PHARMIWEB
    22 Apr 2026
    Share Share
    ClearPoint Neuro Secures Health Canada Nod for Navigation System
    ClearPoint Neuro Secures Health Canada Nod for Navigation System

    20 Apr 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/clearpoint-neuro-announces-canadian-approval-for-its-navigation-system-further-expand-1159082

    ACCESSWIRE
    20 Apr 2026
    Share Share
    ClearPoint Neuro Releases 2025 Q4 And Full-Year Financial Results
    ClearPoint Neuro Releases 2025 Q4 And Full-Year Financial Results

    17 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-17/clearpoint-neuro-reports-fourth-quarter-and-full-year-2025-results

    PHARMIWEB
    17 Mar 2026
    Share Share
    Clearpoint Neuro To Unveil Q4 And Full Year 2025 Results
    Clearpoint Neuro To Unveil Q4 And Full Year 2025 Results

    06 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-06/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2025-results-march-17-2026

    PHARMIWEB
    06 Mar 2026
    Share Share
    ClearPoint Announces Preliminary Unaudited Q4 & Year 2025 Revenue
    ClearPoint Announces Preliminary Unaudited Q4 & Year 2025 Revenue

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/clearpoint-neuro-announces-preliminary-unaudited-fourth-quarter-and-full-year-2025-revenue

    PHARMIWEB
    12 Jan 2026
    Share Share
    Clearpoint Neuro Completes Acquisition Of IRRAS
    Clearpoint Neuro Completes Acquisition Of IRRAS

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/clearpoint-neuro-completes-acquisition-of-irras

    PHARMIWEB
    20 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search